Tangential Versus Segmental Portomesenteric Venous Resection During Pancreatoduodenectomy for Pancreatic Cancer
Thomas F. Stoop(Amsterdam University of Applied Sciences), Caroline Williamsson(Lund University), Hjalmar C. van Santvoort(University Medical Center Utrecht), Daisuke Ban(Tokyo Medical and Dental University), Marc G. Besselink(Amsterdam Neuroscience), Adrienne Molnár(University of Colorado Anschutz Medical Campus), Oskar Franklin(University of Colorado Anschutz Medical Campus), Atsushi Oba(Tokyo Medical and Dental University), Poya Ghorbani(Karolinska University Hospital), Bas Groot Koerkamp, Oskar Swartling(Karolinska University Hospital), Mahsoem Ali(Amsterdam Neuroscience), Ernesto Sparrelid(Karolinska University Hospital), Ingmar F. Rompen(Heidelberg University), Olivier R. Busch(Amsterdam Neuroscience), I. Quintus Molenaar(Utrecht University), Yosuke Inoue(Japanese Foundation For Cancer Research), Marco Del Chiaro(University of Colorado Hospital), Joseph R. Habib(New York University), Paulina Bereza‐Carlson(Lund University), Asif Halimi(Umeå University), Geert Kazemier(European Organisation for Research and Treatment of Cancer), Toshitaka Sugawara(Tokyo Medical and Dental University), Leonard W. F. Seelen(Utrecht University), Bodil Andersson(Lund University), Richard D. Schulick(University of Colorado Anschutz Medical Campus), Freek Daams(Maine Farmland Trust), Ammar A. Javed(NYU Langone Health), Salvador Rodriguez Franco(University of Colorado Anschutz Medical Campus), Tatsunori Miyata(Japanese Foundation For Cancer Research), Niek Geerdink(Amsterdam University Medical Centers), Christopher L. Wolfgang(Johns Hopkins University), Jacobien C.M. Scheepens(Utrecht University), Lysanne P.M. Beuk(Karolinska University Hospital), Roeland F. de Wilde(Karolinska University Hospital), Reeve L. Kruize(Amsterdam University Medical Centers)
Cited by 4
Related Papers
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
|New England Journal of Medicine|2012|5.5k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k